Headlines

Undiagnosed Pre-Diabetes Highly Prevalent in Early Alzheimer’s Disease Study

R. Scott Turner, MD, PhD, began enrolling people with mild to moderate Alzheimer’s disease into a nationwide study last year. Turner says he was “shocked” by how many study participants were found to have pre-diabetes.

DNA abnormalities may contribute to cancer risk in people with type 2 diabetes

People with type 2 diabetes are already known to have a higher risk of cancers, especially blood cancers like lymphoma and leukaemia. The new study, led by scientists at Imperial College London and CNRS in France, suggests that mutations called clonal mosaic events (CMEs) may partly explain why this is.

DiabetesHealth: Experts Target Hypoglycemia at ADA Conference

Experts from across the globe spoke as part of an American Diabetes Association program, bringing to light some of the key concerns for those managing hypoglycemia in diabetes patients.

DiabetesHealth – The Growing Number of Diabetes Therapies

While there is still no cure for diabetes, there is a growing number of therapies available to those battling the disease-and even more are in the works, according to experts who spoke at a recent symposium.

Diabetes Self-Management: Free Online Diabetes Workshop

Are you an older adult with diabetes? Then you may be interested in “Better Choices, Better Health — Diabetes,” a free online workshop from the National Council on Aging.

CNN Health: How bad is that health ‘mistake’?

We know a bad habit when we see one. Smoking? Check! Not exercising? Duh! Gorging on doughnuts? Of course! But what about, say, eating lunch at your desk? Turns out that can be worse for you than you’d think.

JDRF Funded Study Demonstrating Pancreatic Islet Xenograft Survival With Kamada’s AAT

Kamada Ltd. have announced that favorable results from a preclinical study analyzing the effects of the Company’s human Alpha-1 Antitrypsin (AAT), Glassia, in inter-species islet graft transplantation were published in PLOS One

Top 10 Take Aways from ADA 2013 – Part One

Here are the top 10 take aways from the 2013 ADA meeting: from insulin control to artificial pancreas.

Type A Behavior Related to Lower Mortality Risk in Diabetes

Patients with type 1 diabetes and type A behaviors had a significantly lower mortality risk during 22 years of follow-up, investigators reported.

Diabetes Self-Management: Prohibition

How to deal with all the rules and limitations that come with Diabetes? Most people who don’t really understand diabetes see it as, well, a form of prohibition.

Clinical Trial: Triweekly Insulin Degludec a Bad Idea for TII; Stick with Daily Dose

In 2 phase 3 trials examining the concept of triweekly dosing with the long-acting insulin degludec (Tresiba, Novo Nordisk) in patients with type 2 diabetes, the recipients had inferior glucose control and an increased risk for hypoglycemia.

DiabetesMine – Letter to Those Who Make Decisions About Test Strip Accuracy

As you may have heard, some Diabetes Online Community (DOC) advocates have started a social media campaign calling for better accuracy requirements on blood sugar meters and strips.

Science Daily – The Dark Side of Artificial Sweeteners: Expert Reviews Negative Impact

An opinion article published by Cell Press on July 10th in the journal Trends in Endocrinology & Metabolism reviews surprising evidence on the negative impact of artificial sweeteners on health, raising red flags about all sweeteners — even those that don’t have any calories.

Everyday Health – 5 Myths About the Diabetes Diet

Some popular ideas about the best foods for diabetes are downright misleading. Get the facts on the most common diabetes diet myths.

Diabetes Self-Management – Start With Three Drugs?

A new study says that people newly diagnosed with Type 2 can do better if they are immediately started on a three-drug combo. Does this make sense to you? Is it good science or bad medicine?

Solid Food Timing for Babies Tied to TI Diabetes Risk

Infants who receive their first solid food either early or late — before the age of 4 months or at 6 months or older — are at increased risk of developing type 1 diabetes, new research suggests.

DiabetesMine – FDA to Stiffen Regulations on… Lancet Needles?

Right now, the tiny needles that poke our fingers for blood sugar tests are one of the few diabetes supplies not scrutinized by FDA, which makes it easy for us to get them by the box-load without much hassle. But that may soon be changing.

Diabetes Care – Meeting dual HbA1c and LDL-C goals improves diabetes care

Dual achievement of both glycated hemoglobin and low-density lipoprotein cholesterol goals among patients with diabetes is associated with greater clinical and economic benefit than achievement of either goal alone, according to a study published online June 25 in Diabetes Care.

medGadget – Researchers Working to Create Wireless-based Artificial Pancreas for Diabetes

Product development firm Cambridge Consultants (Cambridge, MA) recently announced that it is working with the Institute of Metabolic Science (IMS) at Addenbrooke’s Hospital in Cambridge, UK on groundbreaking research to create an artificial pancreas.

Inhaled Insulin: Biotech Triumph or Future Flop?

In this video, health-care analysts David Williamson and Max Macaluso discuss the cutting edge of insulin treatments, including a new inhalable insulin in development by MannKind.



Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner